Award Abstract # 9818160
GOALI Project: Comprehensive Model of Molecular Transport and Delivery Through the Skin

NSF Org: CBET
Division of Chemical, Bioengineering, Environmental, and Transport Systems
Recipient: THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
Initial Amendment Date: January 8, 1999
Latest Amendment Date: January 8, 1999
Award Number: 9818160
Award Instrument: Standard Grant
Program Manager: Gilbert B. Devey
CBET
 Division of Chemical, Bioengineering, Environmental, and Transport Systems
ENG
 Directorate for Engineering
Start Date: January 15, 1999
End Date: December 31, 2002 (Estimated)
Total Intended Award Amount: $193,565.00
Total Awarded Amount to Date: $193,565.00
Funds Obligated to Date: FY 1999 = $193,565.00
History of Investigator:
  • Johannes Nitsche (Principal Investigator)
    nitsche@eng.buffalo.edu
  • Gerald Kasting (Co-Principal Investigator)
Recipient Sponsored Research Office: SUNY at Buffalo
520 LEE ENTRANCE STE 211
AMHERST
NY  US  14228-2577
(716)645-2634
Sponsor Congressional District: 26
Primary Place of Performance: SUNY at Buffalo
520 LEE ENTRANCE STE 211
AMHERST
NY  US  14228-2577
Primary Place of Performance
Congressional District:
26
Unique Entity Identifier (UEI): LMCJKRFW5R81
Parent UEI: GMZUKXFDJMA9
NSF Program(s): GOALI-Grnt Opp Acad Lia wIndus,
Engineering of Biomed Systems
Primary Program Source: app-0199 
Program Reference Code(s): 0000, 1504, OTHR
Program Element Code(s): 150400, 534500
Award Agency Code: 4900
Fund Agency Code: 4900
Assistance Listing Number(s): 47.041

ABSTRACT

9818160 Nitsche Permeation of molecules through skin is a phenomenon central to the function of drug patches and transdermally delivered drugs, topically applied pharmaceuticals, and a variety of personal cleansing, skin-care and beauty-care products. Better understanding of this process is currently one of the
most important factors underlying biomedical advancement and product development in these areas. It is also key to safety issues and the assessment of risks associated with dermal exposure to chemicals and drugs. Strong need therefore exists to be able to predict how, and how fast, different molecules get through the skin. Filling this need requires a basic research effort aimed at understanding the operative transport processes in microscopic detail.

The proposed GOALI project will combine academic and industrial resources to develop a comprehensive theoretical model for predicting skin permeability, embodying advances difficult or impossible to achieve within either type of setting individually. It is based on collaboration between a basic academic researcher
in the field of microscopic transport phenomena with demonstrated experience in biological applications (Johannes M. Nitsche, State University of New York at Buffalo), and an industrial partner offering uniquely extensive research experience, state-of-the-art experimental capability in skin transport and ultra-
structural studies, and strong interest in improved predictive models (Gerald B. Kasting, the Procter & Gamble Company, Miami Valley Laboratories, Cincinnati). The project will produce theory and computational techniques to predict both the basic permeability properties of the epidermal barrier, and the permeability properties of hair follicles and sweat ducts, which penetrate through this surface barrier and provide a shortcut to deeper tissue and the body's circulation. A distinguishing feature of the proposed theory is physical realism, via the incorporation of extensive information and experimental data on tissue structure and material properties at the microscopic scale. This level of realism will ultimately make it possible to predict how fast a given drug or chemical will penetrate through the skin given only its identity (molecular structure) and a specification of how the application or exposure occurs.

The permeability model resulting from the proposed project will be relevant in some degree to most transdermal drug delivery systems, topically applied drugs and skin-care products currently in use, under development or under contemplation. It will also be applicable to the risk assessment process for a variety of
chemicals and products that contact the skin.

Please report errors in award information by writing to: awardsearch@nsf.gov.

Print this page

Back to Top of page